(Q28730828)

English

Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial

scientific article (publication date: 2012)

In more languages

Statements

scholarly article

0 references

Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial (English)

0 references

0 references

Mary Carrington

7

0 references

Chanson J Brumme

object named as

Chanson J Brumme

2

0 references

Zabrina L Brumme

object named as

Zabrina L Brumme

4

0 references

Bruce D. Walker

9

object named as

Bruce D Walker

0 references

Robert T. Schooley

10

object named as

Robert T Schooley

0 references

Daniel Kuritzkes

11

object named as

Daniel R Kuritzkes

0 references

author name string

Jonathan Z Li

1

0 references

Michael M Lederman

3

0 references

Hongying Wang

5

0 references

John Spritzler

6

0 references

Kathleen Medvik

8

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

3

0 references

e34134

0 references

copyright license

Creative Commons CC0 License

30 March 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

17 March 2017

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

7 April 2017

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

7 April 2017

Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Outcomes after virologic failure of first-line ART in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

The challenge of finding a cure for HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3316607

3 June 2018

HIV cure: controversy, consensus, and a consortium

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Intracellular Staining for HIV-Specific IFN-γ Production: Statistical Analyses Establish Reproducibility and Criteria for Distinguishing Positive Responses

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0034134

21 January 2018

A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22479542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22479542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22479542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22479542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0034134

0 references

2012PLoSO...734134L

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28730828&oldid=2089673470"